Optogenetics approach could restore visual function in retinitis pigmentosa
Companies are exploring light-sensitive proteins method in patients with advanced disease.
Interim global survey analysis reveals opportunities to improve patient outcomes
Data highlights need for educational materials and training resources in DMO and DR.
EURETINA leadership discusses what to expect at the 2022 Congress, outlines Women in Retina programme
Dara Conlon, Executive Vice President of EURETINA, and Prof. Anat Loewenstein, General Secretary of EURETINA, discuss some key features of this year's Congress.
Providing optimal care for patients with diabetic eye disease
Prof Tunde Peto discusses her presentation on providing the best virtual care for patients with diabetic eye disease at EURETINA 2021.
2 Clarke Drive Cranbury, NJ 08512